CCLD
CareCloud, Inc.3.2100
+0.0200+0.63%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q1 '26)
No earnings call transcript available yet
Last Quarter (Q4 '25)
FY Q4 '25
Key Stats
Market Cap
136.09MP/E (TTM)
45.86Basic EPS (TTM)
0.07Dividend Yield
0%Recent Filings
8-K
Declares preferred dividends, clears arrearages
CareCloud declared monthly cash dividends of $0.18229 per share on its 8.75% Series A and Series B Preferred Stock for January through March 2026, payable February to April, with an extra $0.18229 per share on Series B to clear arrearages. Series A faces mandatory conversion history and delisting. Board holds optional redemption rights. Actual results may differ materially.
8-K
CEO shift, AI focus
CareCloud ends co-CEO structure effective January 1, 2026: Stephen Snyder steps up as sole CEO at $350,000 base with 100% target bonus; A. Hadi Chaudhry shifts to Chief Strategy Officer at $300,000. Haq's Chairman pay rises to $350,000; Williams' President salary hits $300,000. Leadership realigns for AI execution. Press release flags 2026 as pivotal AI year.
8-K
Director death sparks Nasdaq non-compliance
CareCloud disclosed the death of independent director John N. Daly on November 24, 2025, triggering non-compliance with Nasdaq rules requiring a majority independent board and a three-member Audit Committee. Nasdaq granted a cure period until the next annual meeting or November 24, 2026. The board plans swift appointment of a new independent director. Compliance breach disclosed.
8-K
Doubles Series B dividends to clear arrears
CareCloud announced a plan on November 10, 2025, to double monthly dividends on its 8.75% Series B Preferred Stock starting January 2026, clearing $3.9 million in arrears from November 2023–December 2024 by Q1 2027. Funded by internal cash flow amid growing recurring revenues and margins, it avoids common stock dilution. Plan completion targeted by early 2027.
10-Q
Q3 FY2025 results
CareCloud posted Q3 revenue of $31.1M, up 9% y/y, with operating income steady at $3.2M despite higher amortization from recent buys; nine-month revenue climbed 4% y/y to $86.1M, operating income jumping 45% y/y to $8.2M. Acquisitions drove growth—Medsphere closed Aug 2025 for $16.5M (cash/notes), adding $11.2M goodwill and $3.4M revenue; RevNu added $0.6M customer relationships. Cash fell to $4.3M with $6.5M on $10M Provident revolver (SOFR+300bps, compliant). Operating cash flow hit $19.9M y/y. Shares exploded. Client retention remains tricky.
IPO
Website
Employees
Sector
Industry
CCCS
CCC Intelligent Solutions Holdi
8.75-0.26
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.35+0.00
DH
Definitive Healthcare Corp.
2.29-0.01
GEHC
GE HealthCare Technologies Inc.
82.25-2.20
HCAT
Health Catalyst, Inc
2.44+0.09
HCTI
Healthcare Triangle, Inc.
2.09-0.18
HSTM
HealthStream, Inc.
23.91-0.47
RMHI
Retrieve Medical Holdings Inc
2.82+0.02
TBRG
TruBridge, Inc.
22.25-0.27
TDOC
Teladoc Health, Inc.
7.41+0.07